The therapeutic potential of exosomes in lung cancer

BackgroundLung cancer (LC) is one of the most common malignancies globally. Besides early detection and surgical resection, there is currently no effective curative treatment for metastatic advanced LC. Exosomes are endogenous nano-extracellular vesicles produced by somatic cells that play an important role in the development and maintenance of normal physiology. Exosomes can carry proteins, peptides, lipids, nucleic acids, and various small molecules for intra- and intercellular material transport or signal transduction. LC cells can maintain their survival, proliferation, migration, invasion, and metastasis, by producing or interacting with exosomes. Basic and clinical data also show that exosomes can be used to suppress LC cell proliferation and viability, induce apoptosis, and enhance treatment sensitivity. Due to the high stability and target specificity, good biocompatibility, and low immunogenicity of exosomes, they show promise as vehicles of LC therapy.ConclusionWe have written this comprehensive review to communicate the LC treatment potential of exosomes and their underlying molecular mechanisms. We found that overall, LC cells can exchange substances or crosstalk with themselves or various other cells in the surrounding TME or distant organs through exosomes. Through this, they can modulate their survival, proliferation, stemness, migration, and invasion, EMT, metastasis, and apoptotic resistance.

Automated summary

Lung cancer is a common malignancy with no effective treatment for metastatic advanced cases. Exosomes, nano-extracellular vesicles produced by somatic cells, play a crucial role in the development and maintenance of normal physiological processes. They can transport various substances and signals, and have shown promise in suppressing cancer cell growth and enhancing treatment sensitivity. Their stability, target specificity, biocompatibility, and low immunogenicity make them a potential vehicle for lung cancer therapy.